Cargando…
The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance
Background: Numerous studies have indicated that the neddylation pathway is closely associated with tumor development. MLN4924 (Pevonedistat), an inhibitor of the NEDD8-activating E1 enzyme, is considered a promising chemotherapeutic agent. Recently, we demonstrated that neddylation of the tumor sup...
Autores principales: | Du, Meng-ge, Peng, Zhi-qiang, Gai, Wen-bin, Liu, Fan, Liu, Wei, Chen, Yu-jiao, Li, Hong-chang, Zhang, Xin, Liu, Cui Hua, Zhang, Ling-qiang, Jiang, Hong, Xie, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120322/ https://www.ncbi.nlm.nih.gov/pubmed/33996822 http://dx.doi.org/10.3389/fcell.2021.667435 |
Ejemplares similares
-
The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice
por: Yu, Huilin, et al.
Publicado: (2022) -
Broad and potent antiviral activity of the NAE inhibitor MLN4924
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2016) -
The novel protective role of P27 in MLN4924-treated gastric cancer cells
por: Zhang, Q, et al.
Publicado: (2015) -
The use of the NEDD8 inhibitor MLN4924 (Pevonedistat) in a cyclotherapy approach to protect wild-type p53 cells from MLN4924 induced toxicity
por: Malhab, Lara J. Bou, et al.
Publicado: (2016) -
Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib
por: Yang, Zelong, et al.
Publicado: (2019)